Nakamoto, Inc. (NAKA)

7.965 +0.82 (+11.55%) USD  |  NASDAQ  |  Oct 21, 11:44
More

Nakamoto Research and Development Expense (TTM)

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2025. Start Trial.
Date Value
September 30, 2025 0.3778M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Astrana Health, Inc. --
Agilon Health, Inc. --
Starling Oncology, Inc. --
American Oncology Network, Inc. --
Regional Health Properties, Inc. --